Fast-grow­ing Shang­hai Phar­ma to plant foot in San Diego, hunt­ing deals in US and Eu­rope

A mul­ti-bil­lion dol­lar Chi­nese phar­ma con­glom­er­ate, blessed with mu­nic­i­pal gov­ern­ment back­ing, is spread­ing its wings to the US and Eu­rope with eyes on R&D, man­u­fac­tur­ing and dis­tri­b­u­tion.

The com­pa­ny, called Shang­hai Phar­ma, is hunt­ing for Amer­i­can cor­po­ra­tions and re­search in­sti­tutes it can part­ner with and ac­quire Chi­na rights from to bol­ster its dis­tri­b­u­tion busi­ness (which re­cent­ly got a boost with the $557 mil­lion ac­qui­si­tion of Car­di­nal Health’s Chi­na unit).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.